Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans
Abstract
Several related human coronaviruses (HCoVs) are endemic in the human population, causing mild respiratory infections1. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiologic agent of Coronavirus disease 2019 (COVID-19), is a recent zoonotic infection that has quickly reached pandemic proportions2,3. Zoonotic introduction of novel coronaviruses is thought to occur in the absence of pre-existing immunity in the target human population. Using diverse assays for detection of antibodies reactive with the SARS-CoV-2 spike (S) glycoprotein, we demonstrate the presence of pre-existing humoral immunity in uninfected and unexposed humans to the new coronavirus. SARS-CoV-2 S-reactive antibodies were readily detectable by a sensitive flow cytometry-based method in SARS-CoV-2-uninfected individuals and were particularly prevalent in children and adolescents. These were predominantly of the IgG class and targeted the S2 subunit. In contrast, SARS-CoV-2 infection induced higher titres of SARS-CoV-2 S-reactive IgG antibodies, targeting both the S1 and S2 subunits, as well as concomitant IgM and IgA antibodies, lasting throughout the observation period of 6 weeks since symptoms onset. SARS-CoV-2-uninfected donor sera also variably reacted with SARS-CoV-2 S and nucleoprotein (N), but not with the S1 subunit or the receptor binding domain (RBD) of S on standard enzyme immunoassays. Notably, SARS-CoV-2-uninfected donor sera exhibited specific neutralising activity against SARS-CoV-2 and SARS-CoV-2 S pseudotypes, according to levels of SARS-CoV-2 S-binding IgG and with efficiencies comparable to those of COVID-19 patient sera. Distinguishing pre-existing and de novo antibody responses to SARS-CoV-2 will be critical for our understanding of susceptibility to and the natural course of SARS-CoV-2 infection.
Competing Interest Statement
The authors have declared no competing interest.
Subject Area
- Biochemistry (11495)
- Bioengineering (8570)
- Bioinformatics (28733)
- Biophysics (14728)
- Cancer Biology (11852)
- Cell Biology (17061)
- Clinical Trials (138)
- Developmental Biology (9275)
- Ecology (13967)
- Epidemiology (2067)
- Evolutionary Biology (18069)
- Genetics (12108)
- Genomics (16555)
- Immunology (11656)
- Microbiology (27535)
- Molecular Biology (11325)
- Neuroscience (59853)
- Paleontology (446)
- Pathology (1839)
- Pharmacology and Toxicology (3169)
- Physiology (4854)
- Plant Biology (10223)
- Synthetic Biology (2827)
- Systems Biology (7271)
- Zoology (1607)